Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
AmerisourceBergen Corporation is a medical distribution business based in the US. AmerisourceBergen Corporation shares (ABC) are listed on the NYSE and all prices are listed in US Dollars. AmerisourceBergen Corporation employs 22,000 staff and has a trailing 12-month revenue of around USD$189.9 billion.
Since the stock market crash in March caused by coronavirus, AmerisourceBergen Corporation's share price has had significant positive movement.
Its last market close was USD$97.8, which is 0.82% up on its pre-crash value of USD$97 and 35.72% up on the lowest point reached during the March crash when the shares fell as low as USD$72.0583.
If you had bought USD$1,000 worth of AmerisourceBergen Corporation shares at the start of February 2020, those shares would have been worth USD$862.76 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,141.33.
|Latest market close||USD$97.8|
|52-week range||USD$71.109 - USD$110.7886|
|50-day moving average||USD$100.3256|
|200-day moving average||USD$98.241|
|Wall St. target price||USD$117.93|
|Dividend yield||USD$1.76 (1.73%)|
|Earnings per share (TTM)||USD$7.531|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-18)||-5.45%|
|1 month (2020-10-23)||-1.59%|
|3 months (2020-08-25)||-0.49%|
|6 months (2020-05-22)||5.00%|
|1 year (2019-11-25)||7.90%|
|2 years (2018-11-23)||11.57%|
|3 years (2017-11-24)||20.40%|
|5 years (2015-11-25)||-1.14%|
Valuing AmerisourceBergen Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AmerisourceBergen Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AmerisourceBergen Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, AmerisourceBergen Corporation shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
AmerisourceBergen Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.4908. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AmerisourceBergen Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
AmerisourceBergen Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$2.5 billion.
The EBITDA is a measure of a AmerisourceBergen Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$189.9 billion|
|Operating margin TTM||1.09%|
|Gross profit TTM||USD$5.2 billion|
|Return on assets TTM||3.1%|
|Return on equity TTM||-315.71%|
|Market capitalisation||USD$20.8 billion|
TTM: trailing 12 months
There are currently 3.3 million AmerisourceBergen Corporation shares held short by investors – that's known as AmerisourceBergen Corporation's "short interest". This figure is 3.3% up from 3.2 million last month.
There are a few different ways that this level of interest in shorting AmerisourceBergen Corporation shares can be evaluated.
AmerisourceBergen Corporation's "short interest ratio" (SIR) is the quantity of AmerisourceBergen Corporation shares currently shorted divided by the average quantity of AmerisourceBergen Corporation shares traded daily (recently around 888212.6344086). AmerisourceBergen Corporation's SIR currently stands at 3.72. In other words for every 100,000 AmerisourceBergen Corporation shares traded daily on the market, roughly 3720 shares are currently held short.
However AmerisourceBergen Corporation's short interest can also be evaluated against the total number of AmerisourceBergen Corporation shares, or, against the total number of tradable AmerisourceBergen Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AmerisourceBergen Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 AmerisourceBergen Corporation shares in existence, roughly 20 shares are currently held short) or 0.0225% of the tradable shares (for every 100,000 tradable AmerisourceBergen Corporation shares, roughly 23 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AmerisourceBergen Corporation.
Find out more about how you can short AmerisourceBergen Corporation stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like AmerisourceBergen Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 8.4
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and AmerisourceBergen Corporation's overall score of 8.4 (as at 01/01/2019) is excellent – landing it in it in the 3rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like AmerisourceBergen Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.11/100
Social score: 5.01/100
Governance score: 1.78/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. AmerisourceBergen Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that AmerisourceBergen Corporation hasn't always managed to keep its nose clean.
|Total ESG score||8.4|
|Total ESG percentile||2.5|
|Level of controversy||3|
Dividend payout ratio: 21.52% of net profits
Recently AmerisourceBergen Corporation has paid out, on average, around 21.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.73% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), AmerisourceBergen Corporation shareholders could enjoy a 1.73% return on their shares, in the form of dividend payments. In AmerisourceBergen Corporation's case, that would currently equate to about $1.76 per share.
While AmerisourceBergen Corporation's payout ratio might seem low, this can signify that AmerisourceBergen Corporation is investing more in its future growth.
AmerisourceBergen Corporation's most recent dividend payout was on 30 November 2020. The latest dividend was paid out to all shareholders who bought their shares by 13 November 2020 (the "ex-dividend date").
AmerisourceBergen Corporation's shares were split on a 2:1 basis on 16 June 2009. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your AmerisourceBergen Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for AmerisourceBergen Corporation shares which in turn could have impacted AmerisourceBergen Corporation's share price.
Over the last 12 months, AmerisourceBergen Corporation's shares have ranged in value from as little as $71.109 up to $110.7886. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while AmerisourceBergen Corporation's is 0.5496. This would suggest that AmerisourceBergen Corporation's shares are less volatile than average (for this exchange).
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Everything we know about the NewRez IPO, plus information on how to buy in.
Everything we know about the Perella Weinberg IPO, plus information on how to buy in.
Everything we know about the Nanobiotix IPO, plus information on how to buy in.
Everything we know about the Diversey IPO, plus information on how to buy in.
Everything we know about the Certara IPO, plus information on how to buy in.
Everything we know about the Arrival IPO, plus information on how to buy in.
Everything we know about the iSpecimen IPO, plus information on how to buy in.
Everything we know about the IDEX Biometrics ASA IPO, plus information on how to buy in.
Steps to owning and managing MYSZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing MG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.